The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
The two biotechs, which have lost most of their share value following lucrative IPOs, are combining in a deal that leaves the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback